Mannkind (MNKD) Payables (2010 - 2026)
Mannkind (MNKD) reported Payables of $16.1 million for Q1 2026, down 60.77% year-over-year from $41.1 million in Q1 2025, and down 64.37% on a QoQ basis from $45.3 million in Q4 2025.
Mannkind (MNKD) has 17 years of Payables data on file, last reported at $16.1 million in Q1 2026.
- Quarterly Payables fell 60.77% year-over-year to $16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.1 million (down 60.77% YoY) and the FY2025 annual result came in at $45.3 million, up 567.17% from the prior year.
- Payables eased to $16.1 million in Q1 2026 per MNKD's latest filing, from $45.3 million in the prior quarter.
- Across five years, Payables topped out at $46.4 million in Q2 2025 and bottomed at $6.4 million in Q3 2024.
- The 5-year median for Payables is $11.1 million (2022), against an average of $18.7 million.
- The widest annual swing landed in 2024, when Payables plunged 61.54%; it then surged 574.94% in 2025.
- Tracing MNKD's Payables over 5 years: stood at $11.1 million in 2022, then declined by 13.32% to $9.6 million in 2023, then declined by 29.1% to $6.8 million in 2024, then surged by 567.17% to $45.3 million in 2025, then plunged by 64.37% to $16.1 million in 2026.
- Per Business Quant, the three latest MNKD Payables figures stand at $16.1 million (Q1 2026), $45.3 million (Q4 2025), and $43.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 16.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.14 Mn |
| Dec 31, 2025 | 45.31 Mn |
| Sep 30, 2025 | 43.49 Mn |
| Jun 30, 2025 | 46.42 Mn |
| Mar 31, 2025 | 41.15 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 9.56 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Dec 31, 2023 | 9.58 Mn |
| Sep 30, 2023 | 16.75 Mn |
| Jun 30, 2023 | 17.13 Mn |
| Mar 31, 2023 | 13.89 Mn |
| Dec 31, 2022 | 11.05 Mn |
| Sep 30, 2022 | 9.87 Mn |
| Jun 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 9.53 Mn |
| Jun 30, 2021 | 7.49 Mn |
| Mar 31, 2021 | 6.71 Mn |
| Dec 31, 2020 | 5.58 Mn |
| Sep 30, 2020 | 51.18 Mn |
| Jun 30, 2020 | 11.21 Mn |
| Mar 31, 2020 | 11.83 Mn |
| Dec 31, 2019 | 9.82 Mn |
| Sep 30, 2019 | 14.18 Mn |
| Jun 30, 2019 | 7.53 Mn |
| Mar 31, 2019 | 6.98 Mn |
| Dec 31, 2018 | 5.38 Mn |
| Sep 30, 2018 | 5.82 Mn |
| Jun 30, 2018 | 9.24 Mn |
| Mar 31, 2018 | 4.98 Mn |
| Dec 31, 2017 | 6.98 Mn |
| Sep 30, 2017 | 5.28 Mn |
| Jun 30, 2017 | 6.54 Mn |
| Mar 31, 2017 | 1.52 Mn |
| Dec 31, 2016 | 3.26 Mn |
| Sep 30, 2016 | 5.09 Mn |
| Jun 30, 2016 | 2.85 Mn |
| Mar 31, 2016 | 582,000.00 |
| Dec 31, 2015 | 15.60 Mn |
| Sep 30, 2015 | 4.44 Mn |
| Jun 30, 2015 | 69.31 Mn |
| Mar 31, 2015 | 102.90 Mn |
| Dec 31, 2014 | 106.75 Mn |
| Sep 30, 2014 | 116.51 Mn |
| Jun 30, 2014 | 5.09 Mn |
| Mar 31, 2014 | 3.64 Mn |
| Dec 31, 2013 | 3.86 Mn |
| Sep 30, 2013 | 122.68 Mn |
| Jun 30, 2013 | 120.16 Mn |
| Mar 31, 2013 | 123.24 Mn |
| Dec 31, 2012 | 119.00 Mn |
| Sep 30, 2012 | 3.17 Mn |
| Jun 30, 2012 | 5.82 Mn |
| Mar 31, 2012 | 2.66 Mn |
| Dec 31, 2011 | 4.62 Mn |
| Sep 30, 2011 | 1.60 Mn |
| Jun 30, 2011 | 1.60 Mn |
| Dec 31, 2010 | 3.29 Mn |